Unaccounted for regression to the mean renders conclusion of article titled "Uric acid lowering in relation to HbA1c reductions with the SGLT2 inhibitor tofogliflozin" unsubstantiated

Diabetes Obes Metab. 2018 Aug;20(8):2039-2040. doi: 10.1111/dom.13323. Epub 2018 May 3.

Authors

Chanaka N Kahathuduwa^{1

2}, Diana M Thomas³, Cynthia Siu⁴, David B Allison⁵

Affiliations

¹ Department of Human Development and Family Studies, Texas Tech University, Lubbock, Texas.
² Department of Physiology, Faculty of Medicine, University of Peradeniya, Peradeniya, Sri Lanka.
³ Department of Mathematics, US Military Academy, West Point, New York.
⁴ COS & Associates Ltd, Central, Hong Kong.
⁵ Department of Epidemiology and Biostatistics, School of Public Health - Bloomington, Indiana University, Bloomington, Indiana.

No abstract available

Publication types

Letter
Research Support, N.I.H., Extramural
Comment

MeSH terms

Benzhydryl Compounds
Diabetes Mellitus, Type 2
Glucosides
Glycated Hemoglobin*
Hypoglycemic Agents
Sodium-Glucose Transporter 2*
Uric Acid

Substances

Benzhydryl Compounds
Glucosides
Glycated Hemoglobin A
Hypoglycemic Agents
Sodium-Glucose Transporter 2
Uric Acid
6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3H),2'-(2H)pyran)-3',4',5'-triol

Grants and funding